EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations

Ashelyn E Sidders iD, Katarzyna M Kedziora, Melina Arts, Jan-Martin Daniel, Stefania de Benedetti, Jenna E Beam, Duyen T Bui, Joshua B Parsons, Tanja Schneider iD, Sarah E Rowe iD, Brian P Conlon iD

eLife · 06.03.2023 · 12

DOI: 10.7554/elife.80246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eLife, online erschienen am 06.03.2023. Verfasst von Ashelyn E Sidders und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, United States. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotic tolerance and antibiotic resistance are the two major obstacles to the efficient and reliable treatment of bacterial infections. Identifying antibiotic adjuvants that sensitize resistant and tolerant bacteria to antibiotic killing may lead to the development of superior treatments with improved outcomes. Vancomycin, a lipid II inhibitor, is a frontline antibiotic for treating methicillin-resistant Staphylococcus aureus and other Gram-positive bacterial infections. However, vancomycin use has led to the increasing prevalence of bacterial strains with reduced susceptibility to vancomycin. Here, we show that unsaturated fatty acids act as potent vancomycin adjuvants to rapidly kill a range of Gram-positive bacteria, including vancomycin-tolerant and resistant populations. The synergistic bactericidal activity relies on the accumulation of membrane-bound cell wall intermediates that generate large fluid patches in the membrane leading to protein delocalization, aberrant septal formation, and loss of membrane integrity. Our findings provide a natural therapeutic option that enhances vancomycin activity against difficult-to-treat pathogens, and the underlying mechanism may be further exploited to develop antimicrobials that target recalcitrant infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusGram-Positive Bacterial InfectionsHumansAnti-Bacterial AgentsVancomycinFatty AcidsMicrobial Sensitivity TestsUridine Diphosphate N-Acetylmuramic Acid

Stichwörter der Autor:innen

Staphylococcus aureusadjuvantantibioticcell wall biosynthesisinfectious diseaselipid IImicrobiologyunsaturated fatty acids

Substanzen

Anti-Bacterial AgentsVancomycinFatty Acidsmuramyl-NAc-(pentapeptide)pyrophosphoryl-undecaprenolUridine Diphosphate N-Acetylmuramic Acid

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Bioinformatics and Analytics Research Collaborative, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Institute for Pharmaceutical Microbiology, University of Bonn, Bonn, Germany.
  • Division of Infectious Diseases, Duke University, Durham, United States.
  • Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, United States.

ORCID-Profile: Ashelyn E Sidders, Tanja Schneider, Sarah E Rowe, Brian P Conlon

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Burroughs Wellcome Fund
  • Cystic Fibrosis Foundation
  • Deutsche Forschungsgemeinschaft
  • Silicon Valley Community Foundation

Zitieren

APA

Sidders, A. E., Kedziora, K. M., Arts, M., Daniel, J. M., de Benedetti, S., Beam, J. E., Bui, D. T., Parsons, J. B., Schneider, T., Rowe, S. E., & Conlon, B. P. (2023). Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations. eLife, 12. https://doi.org/10.7554/elife.80246

Vancouver

Sidders AE, Kedziora KM, Arts M, Daniel JM, de Benedetti S, Beam JE, et al. Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations. eLife. 2023;12. doi:10.7554/elife.80246

BibTeX
@article{Sidders2023,
  author = {Sidders, Ashelyn E and Kedziora, Katarzyna M and Arts, Melina and Daniel, Jan-Martin and de Benedetti, Stefania and Beam, Jenna E and Bui, Duyen T and Parsons, Joshua B and Schneider, Tanja and Rowe, Sarah E and Conlon, Brian P},
  title = {Antibiotic-induced accumulation of lipid II synergizes with antimicrobial fatty acids to eradicate bacterial populations},
  journal = {eLife},
  year = {2023},
  volume = {12},
  doi = {10.7554/elife.80246}
}
Kostenlos starten →